The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trial.
Authors:
- Sandra Schwarzlose-SchwarckSSSandra Schwarzlose-Schwarck
- Christian W ScholzCSChristian W Scholz
- Anne RegiererARAnne Regierer
- Peter MartusPMPeter Martus
- Christian NeumannCNChristian Neumann
- Piet HabbelPHPiet Habbel
- Hongyu LiuHLHongyu Liu
- Chuanbing ZangCZChuanbing Zang
- Jan-Hendrik SchefeJSJan-Hendrik Schefe
- Carsten-Oliver SchulzCSCarsten-Oliver Schulz
- Kurt PossingerKPKurt Possinger
- Jan EuckerJEJan Eucker
- 1 August 2012
- journal article
- Vol. 32 (8) , 3435-41